Jennifer J Knox

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Hepatitis C Virus

Top Venues

Cancer research communications

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Lucy X Ma, Yifan Wang, Osvaldo Espin-Garcia, Michael J Allen, Gun Ho Jang, Amy Zhang, Anna Dodd, Stephanie Ramotar, Shawn Hutchinson, Mustapha Tehfe, Ravi Ramjeesingh, James Biagi, Julie M Wilson, Faiyaz Notta, Sandra E Fischer, George Zogopoulos, Steven Gallinger, Robert C Grant, Rama Khokha, Nathan Chan, Barbara T Grünwald, Jennifer J Knox, Grainne M O'Kane
Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma. British journal of cancer (2023)
Cha Len Lee, Grainne M O'Kane, Warren P Mason, Wen-Jiang Zhang, Pavlina Spiliopoulou, Aaron Richard Hansen, Robert C Grant, Jennifer J Knox, Tracy L Stockley, Gelareh Zadeh, Eric X Chen
Circulating oncometabolite 2-hydroxyglutarate (2HG) as a potential biomarker for isocitrate dehydrogenase (IDH1/2) mutant cholangiocarcinoma. Molecular cancer therapeutics (2023)
Sheron Perera, Gun Ho Jang, Robert C Grant, Faiyaz Notta, Barbara T Grünwald, Steven J Gallinger, Jennifer J Knox, Grainne M O'Kane
hENT1 as a Predictive Biomarker in PDAC-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (15) (2023)
Mark K Doherty, Vincent C Tam, Mairéad Geraldine McNamara, Raymond Jang, David Hedley, Eric Chen, Neesha Dhani, Patricia Tang, Hao-Wen Sim, Grainne M O'Kane, Stephanie DeLuca, Lisa Wang, Theresa Pedutem, Jennifer J Knox
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer. British journal of cancer 127 (8) (2022)
Sheron Perera, Gun Ho Jang, Yifan Wang, Deirdre Kelly, Michael J Allen, Amy Zhang, Robert E Denroche, Anna Dodd, Stephanie Ramotar, Shawn Hutchinson, Mustapha Tehfé, Ravi Ramjeesingh, James J Biagi, Bernard Lam, Julie M Wilson, Sandra E Fischer, George Zogopoulos, Faiyaz Notta, Steven J Gallinger, Robert C Grant, Jennifer J Knox, Grainne M O'Kane
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)